In the past two years, if we look at the changes that took place in the technology panorama, it is observed that Business Intelligence Reporting tools are contributing a great part in the businesses ...
Cognos Therapeutics is a medical technology company focused on developing unique, radically advanced devices for the treatment of neurological diseases including brain and spinal cancers, and ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
In a move rumored for months, Big Blue to pay $5 billion in cash for the business intelligence company to fill out its information management portfolio. Martin LaMonica is a senior writer covering ...
For a long time now, users have been asking what Big Blue plans on doing with all the acquisitions in business intelligence and analytics space (news, site) it made. The release of Cognos 10, which ...
Users consuming data from enterprise resources use Cognos as their primary reporting tool for operational data. The courses listed below are based on user roles and licensing. Please review the roles ...
Cognos upgrades its flagship business intelligence system, while stepping closer to final approval of its merger with IBM. What will the changes mean for end users? Cognos shareholders yesterday gave ...
VB: So what are you doing to better deal with channel conflict? Ashe: We manage it as best as we can. We have this year tried to make a firmer distinction or delineation between the accounts that our ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results